m(6)A methyltransferase METTL3 relieves cognitive impairment of hyperuricemia mice via inactivating MyD88/NF-κB pathway mediated NLRP3-ASC-Caspase1 inflammasome

Int Immunopharmacol. 2022 Dec;113(Pt A):109375. doi: 10.1016/j.intimp.2022.109375. Epub 2022 Nov 5.

Abstract

Background: Recent studies have uncovered that hyperuricemia (HUA) leads to cognitive deficits, which are accompanied by neuronal damage and neuroinflammation. Here, we aim to explore the role of methyltransferase-like 3 (METTL3) in HUA-mediated neuronal apoptosis and microglial inflammation.

Methods: A HUA mouse model was constructed. The spatial memory ability of the mice was assessed by the Morris water maze experiment (MWM), and neuronal apoptosis was analyzed by the TdT-mediated dUTP nick end labeling (TUNEL) assay. Besides, enzyme-linked immunosorbent assay (ELISA) was utilized to measure the contents of inflammatory factors (IL-1β, IL-6, and TNF-α) and oxidative stress markers (MDA, SOD, and CAT) in the serum of mice. In vitro, the mouse hippocampal neuron (HT22) and microglia (BV2) were treated with uric acid (UA). Flow cytometry was applied to analyze HT22 and BV2 cell apoptosis, and ELISA was conducted to observe neuroinflammation and oxidative stress. In addition, the expression of MyD88, p-NF-κB, NF-κB, NLRP3, ASC and Caspase1 was determined by Western blot.

Results: METTL3 and miR-124-3p were down-regulated, while the MyD88-NF-κB pathway was activated in the HUA mouse model. UA treatment induced neuronal apoptosis in HT22 and stimulated microglial activation in BV2. Overexpressing METTL3 alleviated HT22 neuronal apoptosis and resisted the release of inflammatory cytokines and oxidative stress mediators in BV2 cells. METTL3 repressed MyD88-NF-κB and NLRP3-ASC-Caspase1 inflammasome. In addition, METTL3 overexpression enhanced miR-124-3p expression, while METTL3 knockdown aggravated HT22 cell apoptosis and BV2 cell overactivation.

Conclusion: METTL3 improves neuronal apoptosis and microglial activation in the HUA model by choking the MyD88/NF-κB pathway and up-regulating miR-124-3p.

Keywords: Hyperuricemia; METTL3; NLRP3-ASC-Caspase1 inflammasome; The MyD88/NF-κB pathway; miR-124-3p.

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / immunology
  • Animals
  • CARD Signaling Adaptor Proteins / genetics
  • CARD Signaling Adaptor Proteins / immunology
  • Caspase 1 / genetics
  • Caspase 1 / immunology
  • Cells, Cultured
  • Cognitive Dysfunction* / etiology
  • Cognitive Dysfunction* / genetics
  • Cognitive Dysfunction* / immunology
  • Disease Models, Animal
  • Hyperuricemia* / complications
  • Hyperuricemia* / genetics
  • Hyperuricemia* / immunology
  • Inflammasomes* / genetics
  • Inflammasomes* / immunology
  • Methyltransferases* / genetics
  • Methyltransferases* / immunology
  • Mice
  • MicroRNAs / genetics
  • MicroRNAs / immunology
  • Myeloid Differentiation Factor 88 / genetics
  • Myeloid Differentiation Factor 88 / immunology
  • NF-kappa B
  • NF-kappa B p50 Subunit / genetics
  • NF-kappa B p50 Subunit / immunology
  • NLR Family, Pyrin Domain-Containing 3 Protein / genetics
  • NLR Family, Pyrin Domain-Containing 3 Protein / immunology
  • Nervous System / drug effects
  • Nervous System / immunology
  • Nervous System / physiopathology
  • Neuroinflammatory Diseases / etiology
  • Neuroinflammatory Diseases / genetics
  • Neuroinflammatory Diseases / immunology
  • Uric Acid / administration & dosage
  • Uric Acid / adverse effects
  • Uric Acid / pharmacology

Substances

  • Adaptor Proteins, Signal Transducing
  • CARD Signaling Adaptor Proteins
  • Casp1 protein, mouse
  • Caspase 1
  • Inflammasomes
  • Methyltransferases
  • Mettl3 protein, mouse
  • MicroRNAs
  • Mirn124 microRNA, mouse
  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • NF-kappa B p50 Subunit
  • Nfkb1 protein, mouse
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, mouse
  • Pycard protein, mouse
  • Uric Acid